Amino acid-basedÌýformulaÌýis a type ofÌýinfantÌýmilkÌýformulaÌýmade from individualÌýamino acids. It is hypoallergenic and intended forÌýinfantsÌýsuffering from severe allergy to milk and various gastrointestinal conditions, such as food protein-induced enterocolitis syndrome and malabsorption syndromes.
The global Amino Acid Infant Formula market is projected to reach US$ 1288.9 million in 2029, increasing from US$ 753 million in 2022, with the CAGR of 8.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Amino Acid Infant Formula market research.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Amino Acid Infant Formula market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Nestle
Danone Nutricia
Abbott
Mead Johnson
Beingmate
Synutra International
Segment by Type
Powder
Liquid
Segment by Application
Online
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Amino Acid Infant Formula report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Amino Acid Infant Formula Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Amino Acid Infant Formula
1.2 Amino Acid Infant Formula Segment by Type
1.2.1 Global Amino Acid Infant Formula Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Powder
1.2.3 Liquid
1.3 Amino Acid Infant Formula Segment by Application
1.3.1 Global Amino Acid Infant Formula Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Online
1.3.3 Offline
1.4 Global Amino Acid Infant Formula Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Amino Acid Infant Formula Revenue 2018-2029
1.4.2 Global Amino Acid Infant Formula Sales 2018-2029
1.4.3 Global Amino Acid Infant Formula Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Amino Acid Infant Formula Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Amino Acid Infant Formula Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Amino Acid Infant Formula Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Amino Acid Infant Formula Average Price by Manufacturers (2018-2023)
2.4 Global Amino Acid Infant Formula Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Amino Acid Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amino Acid Infant Formula, Product Type & Application
2.7 Amino Acid Infant Formula Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Amino Acid Infant Formula Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amino Acid Infant Formula Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Amino Acid Infant Formula Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amino Acid Infant Formula Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Amino Acid Infant Formula Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Amino Acid Infant Formula Global Amino Acid Infant Formula Sales by Region: 2018-2029
3.2.1 Global Amino Acid Infant Formula Sales by Region: 2018-2023
3.2.2 Global Amino Acid Infant Formula Sales by Region: 2024-2029
3.3 Global Amino Acid Infant Formula Global Amino Acid Infant Formula Revenue by Region: 2018-2029
3.3.1 Global Amino Acid Infant Formula Revenue by Region: 2018-2023
3.3.2 Global Amino Acid Infant Formula Revenue by Region: 2024-2029
3.4 North America Amino Acid Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Amino Acid Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Amino Acid Infant Formula Sales by Country (2018-2029)
3.4.3 North America Amino Acid Infant Formula Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Amino Acid Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Amino Acid Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Amino Acid Infant Formula Sales by Country (2018-2029)
3.5.3 Europe Amino Acid Infant Formula Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amino Acid Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Amino Acid Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Amino Acid Infant Formula Sales by Country (2018-2029)
3.6.3 Asia Pacific Amino Acid Infant Formula Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Amino Acid Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Amino Acid Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Amino Acid Infant Formula Sales by Country (2018-2029)
3.7.3 Latin America Amino Acid Infant Formula Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amino Acid Infant Formula Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Amino Acid Infant Formula Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Amino Acid Infant Formula Sales by Country (2018-2029)
3.8.3 Middle East and Africa Amino Acid Infant Formula Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amino Acid Infant Formula Sales by Type (2018-2029)
4.1.1 Global Amino Acid Infant Formula Sales by Type (2018-2023)
4.1.2 Global Amino Acid Infant Formula Sales by Type (2024-2029)
4.1.3 Global Amino Acid Infant Formula Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Amino Acid Infant Formula Revenue by Type (2018-2029)
4.2.1 Global Amino Acid Infant Formula Revenue by Type (2018-2023)
4.2.2 Global Amino Acid Infant Formula Revenue by Type (2024-2029)
4.2.3 Global Amino Acid Infant Formula Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Amino Acid Infant Formula Price by Type (2018-2029)
5 Segment by Application
5.1 Global Amino Acid Infant Formula Sales by Application (2018-2029)
5.1.1 Global Amino Acid Infant Formula Sales by Application (2018-2023)
5.1.2 Global Amino Acid Infant Formula Sales by Application (2024-2029)
5.1.3 Global Amino Acid Infant Formula Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Amino Acid Infant Formula Revenue by Application (2018-2029)
5.2.1 Global Amino Acid Infant Formula Revenue by Application (2018-2023)
5.2.2 Global Amino Acid Infant Formula Revenue by Application (2024-2029)
5.2.3 Global Amino Acid Infant Formula Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Amino Acid Infant Formula Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Nestle
6.1.1 Nestle Corporation Information
6.1.2 Nestle Description and Business Overview
6.1.3 Nestle Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Nestle Amino Acid Infant Formula Product Portfolio
6.1.5 Nestle Recent Developments/Updates
6.2 Danone Nutricia
6.2.1 Danone Nutricia Corporation Information
6.2.2 Danone Nutricia Description and Business Overview
6.2.3 Danone Nutricia Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Danone Nutricia Amino Acid Infant Formula Product Portfolio
6.2.5 Danone Nutricia Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Amino Acid Infant Formula Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Mead Johnson
6.4.1 Mead Johnson Corporation Information
6.4.2 Mead Johnson Description and Business Overview
6.4.3 Mead Johnson Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mead Johnson Amino Acid Infant Formula Product Portfolio
6.4.5 Mead Johnson Recent Developments/Updates
6.5 Beingmate
6.5.1 Beingmate Corporation Information
6.5.2 Beingmate Description and Business Overview
6.5.3 Beingmate Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Beingmate Amino Acid Infant Formula Product Portfolio
6.5.5 Beingmate Recent Developments/Updates
6.6 Synutra International
6.6.1 Synutra International Corporation Information
6.6.2 Synutra International Description and Business Overview
6.6.3 Synutra International Amino Acid Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Synutra International Amino Acid Infant Formula Product Portfolio
6.6.5 Synutra International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amino Acid Infant Formula Industry Chain Analysis
7.2 Amino Acid Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amino Acid Infant Formula Production Mode & Process
7.4 Amino Acid Infant Formula Sales and Âé¶¹Ô´´ing
7.4.1 Amino Acid Infant Formula Sales Channels
7.4.2 Amino Acid Infant Formula Distributors
7.5 Amino Acid Infant Formula Customers
8 Amino Acid Infant Formula Âé¶¹Ô´´ Dynamics
8.1 Amino Acid Infant Formula Industry Trends
8.2 Amino Acid Infant Formula Âé¶¹Ô´´ Drivers
8.3 Amino Acid Infant Formula Âé¶¹Ô´´ Challenges
8.4 Amino Acid Infant Formula Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Nestle
Danone Nutricia
Abbott
Mead Johnson
Beingmate
Synutra International
Ìý
Ìý
*If Applicable.